Acumen pharmaceuticals to report second quarter financial results on august 8, 2023

Charlottesville, va. and carmel, ind., aug. 01, 2023 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos) (“acumen” or the “company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (aΒos) for the treatment of alzheimer's disease, today announced that the company will report second quarter financial results on tuesday, august 8, 2023. the company will host a conference call and live audio webcast at 8:00 a.m. et to provide a business and financial update.
ABOS Ratings Summary
ABOS Quant Ranking